Skip to Main Content
Volastra
Menu Button
About
Pipeline
Team
Join
News
Contact
News
Armed with $60M series A and Lilly’s backing, Volastra enters clinic via Amgen cancer med
March 16, 2023
SEE ALL NEWS STORIES